Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (68)ga-citrate
2. Ga-67 Citrate
3. Gallium Citrate (1:1); 67ga-labeled
4. Gallium Citrate, 67ga-labeled
5. Gallium(67) Citrate
6. Gallium-67-citrate
1. 27905-02-8
2. Citric Acid, Gallium Salt (1:1)
3. Citric Acid, Gallium(ii) Salt
4. Ht6c49l0zp
5. Gallium;2-hydroxypropane-1,2,3-tricarboxylate
6. 30403-03-3
7. Nsc-15011
8. Einecs 248-721-1
9. Nsc 15011
10. Unii-ht6c49l0zp
11. Gallium 2-hydroxypropane-1,2,3-tricarboxylate
12. Schembl37799
13. Gallium Citrate [mi]
14. Dtxsid50952742
15. 2-hydroxy-1,2,3-propanetricarboxylic Acid Gallium Salt (1:1)
16. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Gallium Salt
| Molecular Weight | 258.82 g/mol |
|---|---|
| Molecular Formula | C6H5GaO7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 257.92910 g/mol |
| Monoisotopic Mass | 257.92910 g/mol |
| Topological Polar Surface Area | 141 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 211 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Radiopharmaceuticals
Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)
ABOUT THIS PAGE
A Gallium Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gallium Citrate, including repackagers and relabelers. The FDA regulates Gallium Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gallium Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gallium Citrate supplier is an individual or a company that provides Gallium Citrate active pharmaceutical ingredient (API) or Gallium Citrate finished formulations upon request. The Gallium Citrate suppliers may include Gallium Citrate API manufacturers, exporters, distributors and traders.
Gallium Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gallium Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gallium Citrate GMP manufacturer or Gallium Citrate GMP API supplier for your needs.
A Gallium Citrate CoA (Certificate of Analysis) is a formal document that attests to Gallium Citrate's compliance with Gallium Citrate specifications and serves as a tool for batch-level quality control.
Gallium Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Gallium Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gallium Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Gallium Citrate EP), Gallium Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gallium Citrate USP).
LOOKING FOR A SUPPLIER?
